Dafna Capital Management LLC Arcturus Therapeutics Holdings Inc. Transaction History

Dafna Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$34.61 - $123.66 $7.95 Million - $28.4 Million	-229,652 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$37.49 - $63.19 $3.02 Million - $5.1 Million	80,635 Added 54.11%	229,652 $9.85 Million
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $1.22 Million - $5.62 Million	96,431 Added 183.38%	149,017 $6.97 Million
Q1 2020 May 15, 2020	SELL	$9.31 - $18.26 $1.13 Million - $2.22 Million	-121,328 Reduced 69.76%	52,586 $715,000
Q3 2019 Nov 14, 2019	BUY	$8.8 - $14.5 $1.51 Million - $2.49 Million	171,514 Added 7146.42%	173,914 $1.79 Million
Q2 2019 Aug 14, 2019	BUY	$5.78 - $9.79 $13,872 - $23,495	2,400 New	2,400 $23,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $450M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.